期刊
FUTURE NEUROLOGY
卷 3, 期 6, 页码 669-681出版社
FUTURE MEDICINE LTD
DOI: 10.2217/14796708.3.6.669
关键词
GTPase; kinase; LRRK2; models; neurodegeneration; neurogenesis; Parkinson's disease
资金
- NIH [NIA AG17216, NINDS NS40256]
- Pacific Alzheimer's Research Foundation
- Robert H and Clarice/ML Simpson Foundation Trust Fellowship
The etiology of Parkinson's disease (PD) was long thought to be due to environmental factors. Following the discovery of autosomal-dominant mutations in the a-synuclein gene, and later recessive mutations in the DJ-1, Parkin and PINK-1 genes, the field of PD genetics exploded. In 2004, it was discovered that mutations in the PARK8 locus -leucine-rich repeat kinase 2 (LRRK2, Lrrk2) - are the most important genetic cause of autosomal-dominant PD. Lrrk2 substitutions also account for sporadic PD in certain ethnic populations and have been shown to increase the risk of PD in Asian populations. Drug therapies targeting Lrrk2 activity may therefore be beneficial to both familial and sporadic PD patients, hence understanding the role of Lrrk2 in health and disease is critical. This review aims to highlight the research effort concentrated on elucidating the functional biological role of Lrrk2, and to provide some future therapeutic perspectives.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据